| 1 | Study | 2.8% | |
| 2 | Patients | 1.05% | |
| 3 | Case | 1.05% | |
| 4 | Disease | 1.05% | |
| 5 | New | 0.7% | |
| 6 | Diabetes | 0.7% | |
| 7 | Screens | 0.7% | |
| 8 | Therapy | 0.7% | |
| 9 | Children | 0.7% | |
| 10 | Report | 0.7% | |
| 11 | Blood | 0.7% | |
| 12 | Young | 0.7% | |
| 13 | Binge | 0.35% | |
| 14 | AstriVax | 0.35% | |
| 15 | Endocrinopathy | 0.35% | |
| 16 | Animal | 0.35% | |
| 17 | Bronchiolitis | 0.35% | |
| 18 | Meta-Analysis | 0.35% | |
| 19 | Drinks | 0.35% | |
| 20 | LivaNova’s | 0.35% | |
| 21 | Clinical | 0.35% | |
| 22 | Saccharin | 0.35% | |
| 23 | Effectively | 0.35% | |
| 24 | Gut | 0.35% | |
| 25 | Parkinsons | 0.35% | |
| 26 | Tolerance | 0.35% | |
| 27 | Loss | 0.35% | |
| 28 | Strategies | 0.35% | |
| 29 | Endocrine | 0.35% | |
| 30 | Tied | 0.35% | |
| 31 | Federal | 0.35% | |
| 32 | Hyponatremia | 0.35% | |
| 33 | Office | 0.35% | |
| 34 | Effectiveness | 0.35% | |
| 35 | Risk | 0.35% | |
| 36 | Vaccine | 0.35% | |
| 37 | Non-occlusive | 0.35% | |
| 38 | Resistance | 0.35% | |
| 39 | Evidence | 0.35% | |
| 40 | Antidepressant | 0.35% | |
| 41 | Spread | 0.35% | |
| 42 | NR2F2 | 0.35% | |
| 43 | Syndrome | 0.35% | |
| 44 | ADHD | 0.35% | |
| 45 | Drug | 0.35% | |
| 46 | Sabah | 0.35% | |
| 47 | Infection | 0.35% | |
| 48 | Nirsevimab | 0.35% | |
| 49 | Ischemia | 0.35% | |
| 50 | Mesenteric | 0.35% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||